The role of lumateperone in the treatment of schizophrenia

Schizophrenia is a devastating mental disorder resulting in marked morbidity and mortality despite the optimal use of all currently available interventions. For this reason, the release of lumateperone (Captyla(R)), also known as ITI-007, an orally administered, atypical antipsychotic provided a wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Alveena Batool, Brašić, James Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326816/
https://www.ncbi.nlm.nih.gov/pubmed/34377435
http://dx.doi.org/10.1177/20451253211034019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326816/
https://www.ncbi.nlm.nih.gov/pubmed/34377435
http://dx.doi.org/10.1177/20451253211034019

Ejemplares similares